KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Nu Skin Enterprises (NUS) over the last 17 years, with Q4 2025 value amounting to $238.6 million.

  • Nu Skin Enterprises' Cash & Equivalents rose 2768.95% to $238.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $238.6 million, marking a year-over-year increase of 2768.95%. This contributed to the annual value of $238.6 million for FY2025, which is 2768.95% up from last year.
  • Per Nu Skin Enterprises' latest filing, its Cash & Equivalents stood at $238.6 million for Q4 2025, which was up 2768.95% from $251.8 million recorded in Q3 2025.
  • In the past 5 years, Nu Skin Enterprises' Cash & Equivalents registered a high of $363.9 million during Q2 2022, and its lowest value of $186.9 million during Q4 2024.
  • Over the past 5 years, Nu Skin Enterprises' median Cash & Equivalents value was $253.9 million (recorded in 2023), while the average stood at $265.3 million.
  • Per our database at Business Quant, Nu Skin Enterprises' Cash & Equivalents tumbled by 3527.37% in 2023 and then soared by 2768.95% in 2025.
  • Nu Skin Enterprises' Cash & Equivalents (Quarter) stood at $339.6 million in 2021, then fell by 22.05% to $264.7 million in 2022, then decreased by 3.27% to $256.1 million in 2023, then dropped by 27.02% to $186.9 million in 2024, then increased by 27.69% to $238.6 million in 2025.
  • Its Cash & Equivalents stands at $238.6 million for Q4 2025, versus $251.8 million for Q3 2025 and $264.2 million for Q2 2025.